Predictors of tissue healing in ulcerative colitis patients treated with anti-TNF. [electronic resource]
- Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver Jan 2017
- 29-33 p. digital
Publication Type: Journal Article; Multicenter Study
1878-3562
10.1016/j.dld.2016.10.008 doi
Adalimumab--therapeutic use Adult Aged Antibodies, Monoclonal--therapeutic use Azathioprine--therapeutic use Colitis, Ulcerative--drug therapy Colonoscopy Drug Therapy, Combination Female Greece Humans Immunosuppressive Agents--therapeutic use Infliximab--therapeutic use Intestinal Mucosa--drug effects Logistic Models Male Middle Aged Nuclear Receptor Subfamily 1, Group F, Member 3--genetics Prospective Studies Severity of Illness Index T-Box Domain Proteins--metabolism Treatment Outcome Tumor Necrosis Factor-alpha--antagonists & inhibitors Wound Healing T-bet Transcription Factor